This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact The Epoch Times Reprints.
Breathing tubes hang next to a man with COVID-19 on a ventilator at a Stamford Hospital Intensive Care Unit in Stamford, Conn. on April 24, 2020. John Moore/Getty Images
New information collected under the federal Right to Try Act shows promise for the new drug ZYESAMI, now in clinical trials for the treatment of serious cases of COVID-19.
The information was collected by a hospital in the U.S. southwest, drug developer NRx announced in a news release Jan. 26.
Nanette Holt is an award-winning Epoch Times reporter and senior features editor covering issues of national interest.
Ms. Holt has had more than 30 years of experience in media and has written for Reader’s Digest, Woman’s World, the Tampa Tribune, the St. Petersburg Times, and others.
